My Treatment Approach: Metastatic Melanoma
April 26th 2022Dr. Michael Atkins and Dr. Evan Lipson discuss the state of metastatic melanoma, contemporary and emerging treatment strategies, and break down a specific patient profile. Their conversation touches on the pros and cons of different treatment strategies for newly diagnosed patients as well as second- and third-line treatment strategies. Dr. Atkins and Dr. Lipson also take time to provide their personal experiences, preferences, and thoughts on prospects involving the treatment and management of metastatic melanoma.
Updates on First-line and Subsequent Treatment Options for Advanced Endometrial Cancer
March 15th 2022This OncLive Insights features a medical oncologist and gynecologic oncologist who share their thoughts on the selection of first-line and subsequent therapy in advanced endometrial cancer. They discuss treatment strategies and novel therapeutics that may improve health outcomes in patients with the disease.
Targetable Gene Rearrangements in Advanced Lung Cancer: Optimized Testing and Management
October 11th 2021This OncLive Insights features 3 experts who share their thoughts on how the treatment landscape of advanced NSCLC is evolving through use of comprehensive genetic sequencing to identify actionable biomarkers. They summarize how novel therapeutics which target driver alterations in ALK, ROS, RET, or NTRK can be leveraged to personalize and optimize management of advanced NSCLC, ultimately improving survival outcomes.